Loading page content
Sam Bourgi is an analyst, writer and financial market commentator featured in and cited by U.S. Congress, Department of Justice, Chicago Board Options Exchange, Barron's and Forbes. He covers stocks, bonds, mutual funds, ETFs, forex, Bitcoin, cryptocurrency, real estate and macroeconomics. He has written over 25,000 articles and over 40 whitepapers and e-books.
Sigmacast expected range · 7–28-day calibrated zone
Forecast batch: 10/16/26
Premium grade: 2026-10-17 05:06 UTC
STX's calibrated band puts the expected move at ±6.8% over 7 days, widening to ±16.0% over 28. Options are currently pricing in line with the band (VRP ≈ 1.10×) — premium screens fair on this scale. That grade is the same at all three horizons — each one's band is below.
Nested 60 / 80 / 95 calibrated expected-range · centered on current price (gold tick)
Macro correlations · context (not confirmation)
8 correlated indicators
Observed historical correlations, not forward signals.
Positively correlated: Total Vehicle Sales (r=+0.83), Crude Oil Production (Monthly) (r=+0.73), BoE Consumer Credit (r=+0.72)
Inversely correlated: Non Defense Goods Orders Ex Air (r=-0.85), 5-Year Note Auction (r=-0.83), Richmond Fed Services Revenues Index (r=-0.81), Producer Price Index (r=-0.74), PPI Ex Food, Energy and Trade YoY (r=-0.68)
As of October 17, 2026, STX is trading at 639.01. Our multi-model Sigmanomics forecast for this stock generates expected price ranges (magnitude, not direction) across 7-day, 14-day, and 28-day horizons, each with a recent-path character readout. Based on ensemble models including SIGMACAST, Σ-Adaptive, and Σ-Trend with model-agreement confidence bands. Updated daily.
Containment = how often the band held (backtest) — magnitude only, not a directional record.
Forecasts generated by Sigmanomics engine. Not financial advice.
Shield Therapeutics plc (STX) is a publicly traded stock covered by the Sigmanomics analytics platform. The STX stock closed at 639.01 on October 16, 2026, reflecting a decline of 7.47% from the previous close of 690.61. STX is listed on the LSE in United Kingdom.
Over the past 30 days, the stock has experienced a strong downtrend with a decline of 24.79%, ranging between 636.36 and 946.34. The price currently trades below its 20-day moving average of 834.83. The 14-day RSI stands at 27.5, in oversold territory.
Over the same 30-day window, daily-return volatility was 4.12%, reflecting heightened price variability for this stock. Across the past 52 weeks, the stock has traded between 209.00 and 1,145.00, with the current price near the midrange of that range.
Daily-return volatility of 4.12% runs elevated for this stock, so price ranges are likely to stay wide — watch how price behaves around its recent range rather than treating any single level as fixed. STX is currently trading 23.46% below its 20-day moving average and sitting in the middle of its 52-week range. Its 14-day RSI reads 27.5, currently in oversold territory.
Auto-generated from Sigmanomics market data. Last update Oct 2026.
Sigmacast forecasts span six horizons — 30-minute, 1-hour, 2-hour, 4-hour, 12-hour, and daily — refreshed continuously as new bars arrive.